Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials
Keyword(s):
Keyword(s):
2021 ◽
2020 ◽
Vol 11
(8)
◽
pp. 1285-1292
◽
2017 ◽
Vol 17
(1)
◽
pp. e63
◽
Keyword(s):